Our Approach
We see a bright future for genetic medicine
Dyno is building a future where gene therapies are safe, effective, and accessible for all.
Our Business
Partnering to create more effective medicines, faster and more cost-effectively than the status quo.
Solving hard problems
We create broadly applicable technologies that solve therapeutic grand challenges and maximize our positive impact on patients.
Focused on platform
We commercialize our technologies as medicines only through partnership, applying our expertise towards building the highest-performance platform for genetic medicines.
Partnership-centric
Unlike companies that compete with their partners, we build technologies that give our partners a competitive edge.
Dyno CEO & Cofounder Eric Kelsic on solving gene delivery
Our Science
Generating and analyzing in vivo data at scale to design exceptionally effective genetic medicines.
The delivery experts
Our platform turns the latest scientific discoveries into high-performance delivery solutions for the eye, muscle, and CNS.
Scaling in vivo insights
We are harnessing DNA multiplexing and machine learning technologies to map in vivo biological fitness landscapes at an unprecedented scale.
Therapeutic superintelligence
As a frontier AI lab, we are pushing the boundaries of biological sequence design to create therapies with the highest potential for patient impact.